Stock DNA
Software Products
JPY 53,282 Million (Small Cap)
90.00
NA
0.00%
-0.67
-999,999.00%
4.82
Revenue and Profits:
Net Sales:
3,430 Million
(Quarterly Results - Dec 2025)
Net Profit:
265 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.20%
EBIT Growth (5y)
9.43%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
90
Industry P/E
Price to Book Value
4.05
EV to EBIT
56.86
EV to EBITDA
48.00
EV to Capital Employed
10.37
EV to Sales
4.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.23%
ROE (Latest)
4.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
8,993.00
7,928.80
13.42%
Operating Profit (PBDIT) excl Other Income
777.80
814.80
-4.54%
Interest
5.30
6.40
-17.19%
Exceptional Items
-199.30
-23.90
-733.89%
Consolidate Net Profit
338.30
485.60
-30.33%
Operating Profit Margin (Excl OI)
73.00%
91.70%
-1.87%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 13.42% vs 25.87% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -30.33% vs 584.91% in Mar 2024






